Rare diseases
Investigational molecules
Locations
A study testing XmAb942 compared to placebo in adults with moderate-to-severe active ulcerative colitis
CroatiaA Study of Long-acting Antibodies SPY001-001 and SPY002 Alone and Combined for Adults with Moderate to Severe Ulcerative Colitis
CroatiaA Study of Depemokimab Compared to Placebo in Adults with Chronic Obstructive Pulmonary Disease and Type 2 Inflammation
CroatiaStudy of trospium chloride and xanomeline tartrate combination for agitation in Alzheimer's disease patients: Long-term safety evaluation
CroatiaLong-term safety study of trospium chloride and xanomeline tartrate combination (KarXT) for treatment of manic episodes in adults with Bipolar I Disorder
CroatiaStudy of evenamide as add-on treatment for patients with treatment-resistant schizophrenia not adequately controlled by current antipsychotic medications
CroatiaStudy of vicadrostat and empagliflozin combination in patients with type 2 diabetes, high blood pressure and cardiovascular disease
CroatiaStudy of BI 1291583 tablets taken once daily for 76 weeks in adults with bronchiectasis
CroatiaStudy of tulisokibart compared to placebo in adults with moderate to severe Crohn's disease
CroatiaStudy of Zasocitinib and Apremilast for Adults with Active Psoriatic Arthritis Who Have Not Used Biologic Medicines
CroatiaStudy of RO7790121 (afimkibart) for Treatment and Long-term Management in Adults with Moderate to Severe Crohn's Disease
CroatiaStudy on Eltrekibart and Mirikizumab for Adults with Moderate to Severe Ulcerative Colitis
CroatiaTell us about your condition – we search every trial in Europe and connect you with the right site.
